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Introduction
The radiation doses calculated using the treatment 
planning systems (TPSs) depend on the type of ap-
plied dose calculation algorithms. At present, Monte 
Carlo (MC) simulation is the most sophisticated and 
accurate algorithm and it is used as the generation of 
benchmark dose distribution. Th ese doses serve as 
the basis for comparison of the results of other less ac-
curate computerized dose calculation methods [1–3]. 
Proper verifi cation procedures allow removal of the 
major sources of errors, such as incorrect application 
of a planning system, its insuffi cient or cursory com-
missioning, as well as an erroneous interpretation of 
the obtained results [4]. 
Numerous problems in radiation dosimetry, radio-
therapy physics and radiation protection have been 
addressed through the use of MC techniques, because 
the complexity of electron and photon transport in 
material makes analytical solutions diffi cult to solve. 
The MC method uses photon and electron transport 
physics to consider the trajectories of individual 
particles, and thus the pattern of dose deposition. 
Each particle’s history is determined by the random 
number generator and millions of particles’ histories 
are traced. The dose distribution is built by summing 
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Abstract. The aim of the present study is to compare dose distributions and their verifi cation in target areas and 
organs at risk (OAR) in conformal and volumetric modulated arc therapy (VMAT) techniques. Proper verifi ca-
tion procedures allow the removal of the major sources of errors, such as incorrect application of a planning 
system, its insuffi cient or cursory commissioning, as well as an erroneous interpretation of the obtained results. 
Three target areas (head and neck, chest, and pelvic) were selected and the treatment was delivered based on 
plans made using collapsed cone convolution and Monte Carlo algorithms with 6-MV photon beams, adopting 
conformal and VMAT techniques, respectively. All the plans were prepared for the anthropomorphic phantom. 
Dose measurements were performed with TL detectors made of LiF phosphor doped with magnesium and ti-
tanium (LiF:Mg,Ti). This paper presents the results of TL measurements and calculated doses, as well as their 
deviations from the treatment planning system (TPS) in the three planned target areas. It was established that 
the algorithms subject to analysis differ, particularly in dose calculations for highly inhomogeneous regions 
(OAR). Aside from the need to achieve the dose intended for the tumour, the choice of irradiation technique in 
teleradiotherapy should be dictated by the degree of exposure to individual critical organs during irradiation. 
While nothing deviated beyond the bounds of what is acceptable by international regulatory bodies in plans 
from TPS, clinically one must be more cautious with the OAR areas. 
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up the energy deposition in each particle’s history 
[5]. Although MC techniques are quite useful in 
dose calculations, they are very intensive computa-
tionally and therefore, other calculation algorithms 
are also used. 
Another algorithm used for dose calculations in 
TPS is the collapsed cone convolution (CCC). This 
dose calculation algorithm is based on a separation of 
the primary photon transport and secondary transport 
of photons and electrons. The total energy released 
per unit mass (TERMA) represents the primary pho-
ton transport. TERMA is the total energy released in 
material. Point-spread kernels h (E, s, r) represent the 
secondary transport of electrons and photons. They 
give rise to the distribution of energy or dose to a point 
r from a single photon interaction at a point s in water. 
The point-spread kernels are often pre-calculated with 
MC simulations for discrete energies. The CCC dose 
algorithm decreases the computational time by col-
lapsing the kernels into a certain number of directions. 
The total energy E or dose is allocated to rectilinear 
directions emerging from the interaction point. This 
effi ciently simplifi es and reduces the number of scatter 
directions from the kernel h [6]. 
However, some reports show large deviations for 
the absolute dose (dose/monitor unit) which occur 
in regions of electronic disequilibrium for the CCC 
algorithm used [7]. 
Dose calculation depends on the algorithm used 
in TPS. In the Radiotherapy Department of the 
Katowice Oncology Center, dose calculations for 
patients treated with external photon beams have 
been routinely performed using the Oncentra Mas-
terPlan (Ve rsion 4.3) TPS for conformal and Monaco 
(Ve rsion 3.30.01) TPS for VMAT techniques. They 
calculate doses on the basis of CCC and MC algo-
rithms, respectively. 
The aim of this publication is to compare these 
two algorithms and verify the results by measuring 
the doses in target areas (head and neck, chest, and 
pelvic) and their respective organs at risk (OAR). Er-
rors in these algorithms can lead to increased doses to 
OAR as well as not enough radiation to the tumour. 
The doses absorbed in the targets and selected 
organs were evaluated using the anthropomorphic 
phantom ATOM® (CIRS – Computer Imaging 
Reference Systems, Inc.) and thermoluminescent 
detectors (TLD). 
Materials and methods
The measurements were performed with LiF:Mg,Ti 
TL detectors (MTS-N, TLD Poland) in the form 
of cylindrical pellets with a diameter of 4.5 mm, a 
thickness of 0.8 mm and the effective atomic number 
Zeff = 8.14. The TL response of pellets was acquired 
by the RA’04 TLD reader system manufactured in 
Poland. Prior to each main read-out, the pellets 
were annealed in a furnace in two phases: fi rst at 
the temperature of 400°C for 1 h and then at 100°C 
for 2 h. Next, they were cooled rapidly by transfer-
ring them on top of an aluminium block at room 
temperature. The scheme for pellets treatment was 
as follows: annealing – TL read-out for background 
reduction – irradiation – TL read-out – annealing. 
Prior to the phantom dose measurements, each 
detector underwent calibration in reference conditions 
using beams of the same radiation quality as used in 
treatment planning. The calibration during emission 
of therapeutic photon beam was performed on an ac-
celerator with a nominal energy of 6 MV, skin surface 
distance (SSD) of 100 cm and fi eld size of 10 × 10 cm2. 
For the purposes of calibration, special holes to contain 
TLD pellets were made in a solid water slab (density 
of 1.02 g/cm3). The holes were arranged symmetrically 
around the slab centre within a 10-cm square fi eld. A 
cylindrical Farmer-type ionization chamber of 0.6 cm3 
volume was used as a reference dosimeter for TLDs 
calibration; it was also used for comparison of the 
read-outs. All calibrated detectors had to be exposed 
to the calibration dose at the same time to minimize 
differences in irradiation conditions, and thus differ-
ences in future dose read-outs. 
The patient (adult male) was simulated by 
the ATOM® phantom from CIRS. Its image was 
obtained using Siemens CT-Scan and then was 
copied to the radiotherapy planning system for the 
purposes of the conformal and VMAT optimization 
techniques. 
Given the objectives of this study, three treat-
ment plans were prepared for three selected target 
areas: (a) head and neck, (b) chest, and (c) pelvic 
for conformal and VMAT techniques. The planned 
treatment was delivered with 6-MV beams for both 
radiotherapy techniques. A  dose comparison for in-
dividual points for the two different treatment tech-
niques could be made because the plans concerned 
the same localization of the isocentres. The doses 
were calculated using the CCC and MC algorithms. 
The doses calculated for the anthropomorphic phan-
tom with the use of two algorithms were compared 
with the doses measured with calibrated TLD pellets 
placed inside the phantom during the irradiation. 
Head and neck area
In the head and neck area, a hypothetical clinical 
target volume (CTV) equal to 31.62 cm3 with a plan-
ning target volume (PTV) of 11.447 cm3 was located 
in the brain. The OARs in this case were the brain, 
brainstem, right eye and left eye. A treatment plan was 
created with fi ve noncoplanar beams in the conformal 
technique and 144 plan segments in the VMAT tech-
nique. The total planned dose for the target volume 
was about 54 Gy and it was given in 27 fractionations 
(2 Gy). The fi nal plan required 186 MUs per gray 
of prescribed dose in the conformal technique and 
394 MUs per gray in the VMAT technique. 
Chest area
In the chest area, the CTV was equal to 51.3 cm3, the 
PTV was 180.3 cm3 and it was located in the left lung. 
The OARs in this case were as follows: the right lung, 
heart, spinal canal, vertebral arch and vertebral body. 
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A treatment plan was created with four noncoplanar 
beams/56 plan segments. The total planned dose for 
the target volume was about 46 Gy and it was given 
in 23 fractionations (2 Gy). The fi nal plan required 
286 MUs in the conformal technique and 320 MUs 
per gray of prescribed dose in the VMAT technique. 
Pelvic area
In the pelvic area, the CTV was equal to 49.78 cm3, 
the PTV equaled 155.55 cm3 and it was located 
in the prostate. The OARs in this case were the blad-
der, rectum, right femoral head and left femoral head. 
A treatment plan was developed with fi ve noncoplanar 
beams/54 plan segments with the prescribed dose of 
76 Gy (2 Gy/fraction, 38 fractions). The fi nal plan 
required 174 MUs in the conformal and 304 MUs 
per gray of prescribed dose in the VMAT technique. 
The TLDs were placed at different points within 
the irradiated area, in sets of three per each point 
with a view to checking the repeatability of the mea-
surements. The location of the points was selected 
so as to include three different dose distribution 
regions: target area, CTV, PTV and OAR. Figures 1–3 
illustrate in detail the locations of the measurement 
points for three regions: head and neck, chest, and 
pelvic. The dose measured at a single point within 
a structure was an arithmetic mean of the read-outs 
of the three detectors placed at that point. 
In order to evaluate and analyse the data, the 
formula as indicated in AAPM Task Group 119 was 
used. The dose difference (D in %) was calculated as 
(1)
where DPLAN is the planned dose at TPS and DTLD 
is the mean measured dose in the detectors. Later, 
the results of the calculations were evaluated in 
accordance with the International Atomic Energy 
Agency (IAEA) recommendations and criteria [1]. 
Results and discussion
The analyses of the results for the cases presented in 
Figs. 1–3 were carried out based on the international 
recommendations of IAEA [1] and the European 
Society for Radiotherapy and Oncology (ESTRO) 
[8]. The maximum accepted deviations of dose 
values, as calculated by the computerized TPS from 
the actual doses measured in selected regions of a 
certain photon fi eld, were determined as stipulated 
in the above recommendations. Tables 1–3 present 
the results obtained in the selected target areas. 
Head and neck area
W hen analysing the data in the conformal technique 
at the points of the CTV area presented in Table 1, it 
must be observed that the differences (D) between 
the TPS-calculated doses and TLD-measured doses 
were in a range from –1.45% (3wk) to a maximum 
of –2.45% (2wk). This means that the doses mea-
sured by the detectors were higher than the doses 
calculated by the treatment plan. In clinical practice, 
as defi ned in various international recommendations 
such as IAEA [1] and ESTRO [8], the difference be-
tween the scheduled dose and the dose obtained by a 
patient should not exceed 5%. TL detectors absorbed 
doses similar to those planned by the treatment plan.
Fig. 1. Location of the measurement points from the phan-







Table 1. Results of the measurements and deviations of the TPS calculated doses from the measured ones for the 
planned target head and neck area 
Location No. DPLANc [Gy] 
DTLD [Gy] 









Brain 1k 1.51 1.49 (2.87)   1.32 1.12 (2.03) 1.16 (2.79) –3.57
Brain 2k 1.14 1.12 (2.38)   1.75 1.15 (2.26) 1.18 (2.25) –2.61
CTV 1wk 2.07 2.12 (2.28) –2.42 2.08 (0.86) 2.11 (1.82) –1.44
CTV 2wk 2.04 2.09 (2.88) –2.45 2.07 (0.98) 2.13 (1.98) –2.90
CTV 3wk 2.07 2.10 (2.02) –1.45 2.08 (1.06) 2.15 (1.28) –3.37
CTV 4wk 2.07 2.11 (1.17) –1.93 2.09 (0.67) 2.15 (1.10) –2.87
Brainstem 5pk 0.54 0.56 (3.55) –3.70 0.89 (4.36) 0.91 (2.30) –2.25
Left eye 6sk 0.02   0.021 (2.11) –5.00   0.018 (5.26)   0.019 (2.38) –5.56
Right eye 7sk 0.06   0.059 (1.96)   1.67   0.049 (2.96)   0.047 (2.87)   4.08
DPLANc – dose calculated using CCC algorithm, DPLANv – dose calculated using Monte Carlo algorithm, DTLD – dose measured 
with TLDs, c,v – percentage deviation of TLD measured dose from the calculated by the planning system. 
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The biggest difference in critical organs was ob-
served in the left eye, where the difference between 
doses was –5.00% (6sk). The smallest difference in 
the doses emerged in the brain (1k) and was equal to 
1.32%. It should be noted that the obtained results 
did not take into account the measurement uncer-
tainties () of the doses measured by TL detectors. 
The highest uncertainty (5pk) was 3.55% and the 
lowest (4wk) was 1.17%.
As regards the analysis of the VMAT data (Table 1) 
in the CTV area, the doses measured by the detectors 
were higher than the doses calculated by the treatment 
plan by –1.44% (1wk) to a maximum value of –3.37% 
(3wk). These results met the clinical assumptions.
The big gest differences in critical organs can be 
seen in the left and right eyes (6sk and 7sk points), 
where the differences between doses were –5.56% 
and 4.08%, respectively. The smallest difference 
between the doses was in the brainstem (5pk), equal 
to –2.25%. In the case of VMAT, the measurement 
uncertainties of the TL detectors were lower than 
those in the conformal technique and ranged from 
a maximum value of 2.87% at 7sk to 1.10% at 4wk. 
Table 2. Results of the measurements and deviations of the TPS calculated doses from the measured ones for the 
planned target chest area 






± DPLANv [%] 
DTLD [Gy] 
± DTLD [%] 
v
[%]
Heart s1 1.91 1.96 (1.65) –2.62 1.92 (0.63) 1.95 (1.73) –1.56
Heart s2 1.04 1.07 (3.92) –2.88 0.79 (1.90) 0.81 (2.62) –2.53
PTV p1 1.88 1.95 (1.67) –3.72 2.08 (2.16) 2.14 (1.54) –2.88
CTV p2 1.95 1.99 (1.66) –2.05 2.09 (0.38) 2.18 (0.16) –4.31
CTV p3 1.98 2.09 (2.43) –5.56 2.04 (0.39) 2.14 (0.30) –4.90
PTV p4 1.94 2.03 (1.70) –4.64 2.01 (2.79) 2.08 (2.66) –3.48
Right lung pp1 0.69 0.71 (1.70) –2.90 0.88 (3.31) 0.86 (4.09)   2.27
Right lung pp2 0.57 0.58 (4.58) –1.75 0.66 (5.34) 0.64 (4.95)   3.03
Right lung pp3 0.51 0.52 (4.78) –1.96 0.89 (3.49) 0.87 (3.52)   2.25
Vertebral arch k1 1.70 1.74 (1.85) –2.35 0.89 (2.13) 0.92 (2.57) –3.37
Spinal canal k2 1.10 1.12 (1.91) –1.82 0.91 (1.86) 0.94 (1.89) –3.30
Vertebral arch k3 0.87 0.86 (4.19)   1.15 1.52 (0.79) 1.54 (2.16) –1.32
Vertebral arch k4 0.75 0.77 (4.51) –2.67 0.83 (2.30) 0.84 (6.56) –1.20
Vertebral arch k5 1.30 1.32 (1.80) –1.54 1.44 (0.62) 1.46 (1.16) –1.39
Table 3. Results of the measurements and deviations of the TPS calculated doses from the measured ones for the 
planned target pelvic area 
Location No. DPLANc[Gy] 
DTLD [Gy] 




± DPLANv [%] 
DTLD [Gy] 
± DTLD [%] 
v
[%]
Right femoral head   1 1.01 1.03 (2.83) –1.98 0.93 (1.40) 0.96 (3.12) –3.23
Left femoral head   2 0.97 0.98 (1.70) –1.03 0.86 (1.51) 0.88 (2.69) –2.33
CTV   3 2.02 2.10 (1.72) –3.96 2.05 (0.29) 2.15 (1.45) –4.88
Rectum   4 0.40 0.38 (1.01)   5.00 0.79 (1.65) 0.77 (2.08)   2.53
Rectum   5 1.40 1.36 (0.82)   2.86 1.01 (2.57) 0.99 (2.65)   1.98
Rectum   6 1.49 1.45 (1.66)   2.68 1.69 (4.49) 1.66 (1.63)   1.78
PTV   7 2.01 2.07 (0.80) –2.99 2.05 (0.44) 2.12 (1.39) –3.41
CTV   8 2.02 2.05 (0.57) –1.49 2.06 (0.24) 2.12 (2.48) –2.91
PTV   9 2.05 2.11 (0.17) –2.93 2.06 (0.53) 2.11 (2.06) –2.43
CTV 10 2.04 2.09 (2.85) –2.45 2.03 (0.44) 2.11 (1.46) –3.94
Fig. 2. Location of the measurement points from the phan-
tom chest area described in Table 2.
Fig. 3. Location of the measurement points from the phan-
tom pelvic area described in Table 3.
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Chest area
In the chest area, the analysis of the data in the con-
formal technique (Table 2) reveals that the biggest 
differences (D) between the TPS-calculated doses 
and TLD-measured doses can be seen at the points of 
the CTV and PTV areas. The differences (D) were in 
a range from –2.05% (p2) to a maximum of –5.56% 
(p3). It has once again been found that the doses 
measured by the detectors were higher than the doses 
calculated by the treatment plan. The obtained 
values were on the borderline of the clinical as-
sumptions.
The biggest difference in critical organs was 
observed in the heart (s1 and s2 points) where the 
values oscillate between –2.62% and –2.88%. The 
smallest difference in doses emerged in the vertebral 
arch (k3) and was equal to 1.15%. As in the head and 
neck case, the presented results did not take into ac-
count the measurement uncertainties () of the doses 
measured by TL detectors. The highest uncertainty 
(pp3) was 4.78% and the lowest (s1) was 1.65%.
The analysis of the chest area data for VMAT 
(Table 2) shows that the biggest differences (D) 
can be seen at the points of the CTV and PTV ar-
eas. The doses measured by the detectors at these 
points were higher than the doses calculated by the 
treatment plan by –2.88% (p1), up to a maximum 
value of –4.9% (p3). These results met the clinical 
assumptions.
The biggest difference in critical organs can be 
seen in the vertebral arch (k4 and k1 points), where 
the differences between doses were –1.20% and 
3.37%, respectively. The differences equal to –1.56% 
and –2.53% were present in the heart. The measure-
ment uncertainties of the TL detectors were higher 
than those in the conformal technique and ranged 
from a maximum value of 6.56% at k4 to 0.16% at p2. 
Pelvic area
In the pelvic area, the analysis of the data in the 
conformal technique (Table 3) reveals that the big-
gest differences (D) between the TPS-calculated 
doses and TLD-measured doses can be also seen at 
the points of the CTV and PTV areas. In this area 
(CTV: points 3, 8, 10, PTV: points 7, 9), the doses 
measured by the detectors were higher than the 
doses calculated by the treatment plan by –1.49% 
(point 8) up to –3.96% (point 3). The values met 
the clinical assumptions.
The biggest difference in critical organs was ob-
served in the rectum (point 4), where the maximum 
value was equal to 5%. The smallest value equal 
to –1.03% was for the left femoral head (point 2). 
The presented results did not take into account the 
measurement uncertainties () of doses measured 
by TL detectors. The highest uncertainty (point 10) 
was 2.85% and the lowest (point 9) was 0.17%.
The analysis of pelvic area data for VMAT 
(Table 3) shows that the biggest differences (D) can 
be once again seen at the points of the CTV and 
PTV areas. The doses measured by the detectors at 
these points were higher than the doses calculated 
by the treatment plan by –2.43% (point 9) up to a 
maximum value of –4.88% (point 3). These results 
met the clinical assumptions.
The biggest difference in critical organs can be 
seen in the right femoral head (point 1) and it is 
equal to –3.23%, while the smallest difference was 
equal to 1.78% and was observed in the rectum 
(point 6). In the VMAT technique, the measurement 
uncertainties of the TL detectors were higher than 
those in the conformal technique and ranged from 
a maximum value of 3.12% at point 1 to 1.39% at 
point 7.
When comparing the treat ment plans prepared 
for two treatment techniques, conformal and VMAT, 
differences in the dose rates in the target and in the 
OAR ar eas can be observed. 
Head and neck area
When comparing the two treatment techniques 
we find that VMAT delivers a higher dose of 
0.02 Gy in the target area and a dose of 0.36 Gy in 
an organ at risk such as the brainstem. However, if 
we take into account the criterion of eye and brain 
protection, the doses at these points were lower by 
0.007 Gy and 0.19 Gy for VMAT. 
It should be emphasized that the presented doses 
apply only to one irradiation fraction, and if all 
the fractions from the treatment plan are included 
(27 fractions), the doses will be signifi cantly differ-
ent. In such a situation, using the VMAT technique, 
one will provide a dose larger by approximately 
0.41 Gy on the target and up to 9.59 Gy on the brain-
stem throughout the entire treatment cycle as com-
pared with the conformal technique. The conformal 
technique will provide a dose higher by approximately 
0.19 Gy in both eyes and by about 5.13 Gy in the brain. 
Chest area
Comparing the two treatment techniques, a higher 
dose of 0.12 Gy in the target area and of 0.22 Gy in 
the right lung for the VMAT technique can be noted. 
However, if we apply the criterion of protection of 
the heart and the vertebral bone, the doses at these 
points are lower by 0.12 Gy (heart) and 0.03 Gy 
(vertebral bone) for the VMAT technique. 
In a 23 fractions case, using the VMAT tech-
nique throughout the whole treatment cycle, the 
target would obtain a dose higher by approximately 
2.67 Gy and the right lung by as much as 4.97 Gy 
in comparison with the conformal technique. The 
conformal technique will provide a larger dose of 
approximately 2.76 Gy in the heart and of approxi-
mately 0.57 Gy in the bone with a spinal canal. 
Pelvic area
Comparison of the two treatment techniques shows 
that a higher dose of 0.02 Gy in the target area and 
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of 0.07 Gy in the rectum for the VMAT technique 
can be observed. However, if we adopt the criterion 
of protection of the femoral heads, the doses at these 
points are lower by 0.10 Gy for the VMAT technique. 
For the 38 fractions, the doses will be signifi -
cantly different. In such a case, using the VMAT 
technique throughout the whole treatment cycle, the 
target would obtain a dose higher by approximately 
0.87 Gy and the rectum by as much as 2.58 Gy in 
comparison with the conformal technique. The 
conformal technique will provide a larger dose of 
approximately 3.59 Gy in the femoral heads. 
Conclusions
All the treatment plans were verifi ed using TLDs, 
and it can be stated that the doses in the target and 
in the critical organs are consistent with the doses 
given in the TPS. 
As regards the comparison of the two treatment 
techniques, a more homogeneous dose distribution 
and its increase in the target for all the tumours 
under investigation can be observed in the VMAT 
technique rather than in the conformal technique. 
On the whole, it is benefi cial given the full irradia-
tion of the tumour. 
VMAT allows reducing dose in most OARs with-
out compromising target coverage [9]. 
According to various authors, VMAT seems to 
be the optimal treatment planning technique in the 
dosimetric comparison with different treatment 
methods in lung or breast cancer [10, 11]. It allows 
maximal lung and heart sparing when compared to 
the conformal technique. In addition, it allows dose 
escalation when needed, with minimal increased 
dose to OARs. The main concern when using VMAT 
is the spreading of low-radiation dose to the normal 
tissue and hence an increased integral dose. This 
raises concerns of possible increased risk of sec-
ondary cancer. The calculated doses to the OARs 
in head and neck and pelvic area were considerably 
lower with VMAT than with the conformal tech-
nique. Therefore, the estimated risk for secondary 
cancer should be considerably lower with VMAT 
for this area, which is consistent with other pub-
lications [12]. Although there is evidence to show 
that VMAT has a defi nite place in the treatment of 
many tumours, it cannot be considered the universal 
solution for all clinical scenarios because each case 
must be evaluated on an individual basis to select 
the most appropriate radiation technique that will 
give optimal results. 
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